The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Antiviral Drug Resistance: Mechanisms and Clinical Implications
Open accessAbstract
Summary Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
Elion, G. B., Furman, P. A., Fyfe, J. A., Miranda, P. D., Beauchamp, L., & Schaeffer, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5716 · Cited by 1,591
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., de Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802878 · Cited by 1,181
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Ma, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.020 · Cited by 881
Tenney, D. J., Rose, R. E., Baldick, C. J., Pokornowski, K. A., Eggers, B. J., Fang, J., Wichroski, M. J., Xu, D., Yang, J., Wilber, R. B., et al. (2009) · Hepatology · doi:10.1002/hep.22841 · Cited by 804
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
Allen, M. I., Deslauriers, M., Andrews, W. C., Tipples, G. A., Walters, K.-A., Tyrrell, D. L., Brown, N., & Condreay, L. D. (1998) · Hepatology · doi:10.1002/hep.510270628 · Cited by 793
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J.-P., Kovarik, J., Brennan, P. J., Norman, D., Mendez, R., Keating, M. R., Coggon, G. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401903 · Cited by 712
Lai, C., Dienstag, J., Schiff, E., Leung, N. W. Y., Atkins, M., Hunt, C., Brown, N., Woessner, M., Boehme, R., & Condreay, L. (2003) · Clinical Infectious Diseases · doi:10.1086/368083 · Cited by 634
Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00939-9 · Cited by 564
Liaw, Y., Gane, E., Leung, N., Zeuzem, S., Wang, Y., Lai, C. L., Heathcote, E. J., Manns, M., Bzowej, N., Niu, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.026 · Cited by 562
Keeffe, E. B., Dieterich, D. T., Han, S.-H. B., Jacobson, I. M., Martin, P., Schiff, E. R., & Tobias, H. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.021 · Cited by 558
Limaye, A. P., Corey, L., Koelle, D. M., Davis, C. L., & Boeckh, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02607-6 · Cited by 509
Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy
Bacon, T. H., Levin, M. J., Leary, J. J., Sarisky, R. T., & Sutton, D. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.114-128.2003 · Cited by 504
The Antiviral Activities of Artemisinin and Artesunate
Efferth, T., Romero, M. R., Wolf, D. G., Stamminger, T., Marin, J. J. G., & Marschall, M. (2008) · Clinical Infectious Diseases · doi:10.1086/591195 · Cited by 503
Markowitz, J. S., Martin, P., Conrad, A. J., Markmann, J. F., Seu, P., Yersiz, H., Goss, J. A., Schmidt, P., Pakrasi, A., Artinian, L., et al. (1998) · Hepatology · doi:10.1002/hep.510280241 · Cited by 485
Herpes simplex virus resistance to antiviral drugs
Morfin, F., & Thouvenot, D. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00263-9 · Cited by 438
Benhamou, Y., Bochet, M., Thibault, V., Di Martino, V., Caumes, E., Bricaire, F., Opolon, P., Katlama, C., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510300525 · Cited by 424
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
Sherman, M., Yurdaydin, C., Sollano, J., Silva, M., Liaw, Y., Cianciara, J., Boron–Kaczmarska, A., Martin, P., Goodman, Z., Colonno, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.007 · Cited by 413
van Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389
Wagstaff, A. J., Faulds, D., & Goa, K. L. (1994) · Drugs · doi:10.2165/00003495-199447010-00009 · Cited by 386
Crumpacker, C. S. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609053351007 · Cited by 382
Safrin, S., Crumpacker, C., Chatis, P., Davis, R., Hafner, R., Rush, J., Kessler, H. A., Landry, B., & Mills, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108223250805 · Cited by 375
Coen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L., & Knipe, D. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4736 · Cited by 362
Kobashigawa, J. A., Miller, L. W., Russell, S. D., Ewald, G. A., Zucker, M. J., Goldberg, L. R., Eisen, H. J., Salm, K., Tolzman, D., Gao, J., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01290.x · Cited by 329
Sheldon, J., Camino, N., Rodés, B., Bartholomeusz, A., Kuiper, M., Tacke, F., Núñez, M., Mauss, S., Lutz, T., Klausen, G., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000612 · Cited by 285
Das, K., Xiong, X., Yang, H., Westland, C. E., Gibbs, C. S., Sarafianos, S. G., & Arnold, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4771-4779.2001 · Cited by 274
Gane, E. J., Angus, P. W., Strasser, S., Crawford, D. H. G., Ring, J., Jeffrey, G. P., & McCaughan, G. W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.005 · Cited by 273
Lampertico, P., Viganò, M., Manenti, E., Iavarone, M., Lunghi, G., & Colombo, M. (2005) · Hepatology · doi:10.1002/hep.20939 · Cited by 272
Moraleda, G., Saputelli, J., Aldrich, C. E., Averett, D., Condreay, L., & Mason, W. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9392-9399.1997 · Cited by 263
Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus
Delaney, W. E., Ray, A. S., Yang, H., Qi, X., Xiong, S., Zhu, Y., & Miller, M. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00138-06 · Cited by 259
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Yim, H. J., Hussain, M., Liu, Y., Wong, S. N., Fung, S. K., & Lok, A. S. F. (2006) · Hepatology · doi:10.1002/hep.21290 · Cited by 253
Winston, D. J., Young, J.-A. H., Pullarkat, V., Papanicolaou, G. A., Vij, R., Vance, E., Alangaden, G. J., Chemaly, R. F., Petersen, F., Chao, N., et al. (2008) · Blood · doi:10.1182/blood-2007-11-121558 · Cited by 245
ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPY
Burns, W., Santos, G., Saral, R., Laskin, O., Lietman, P., Mclaren, C., & Barry, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91620-8 · Cited by 240
Stránská, R., Schuurman, R., Nienhuis, E., Goedegebuure, I. W., Polman, M., Weel, J. F., Wertheim-Van Dillen, P. M., Berkhout, R. J. M., & van Loon, A. M. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.04.002 · Cited by 238
Schiff, E., Lai, C.-L., Hadziyannis, S., Neuhaus, P., Terrault, N., Colombo, M., Tillmann, H., Samuel, D., Zeuzem, S., Villeneuve, J.-P., et al. (2007) · Liver Transplantation · doi:10.1002/lt.20981 · Cited by 235
Wagstaff, A. J., & Bryson, H. M. (1994) · Drugs · doi:10.2165/00003495-199448020-00007 · Cited by 232
Marzano, A., Salizzoni, M., Debernardi-Venon, W., Smedile, A., Franchello, A., Ciancio, A., Gentilcore, E., Piantino, P., Barbui, A. M., David, E., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00080-0 · Cited by 223
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Ljungman, P. (2001) · Blood · doi:10.1182/blood.v97.2.388 · Cited by 220
Margeridon‐Thermet, S., Shulman, N. S., Ahmed, A., Shahriar, R., Liu, T., Wang, C., Holmes, S. P., Babrzadeh, F., Gharizadeh, B., Hanczaruk, B., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597808 · Cited by 206
Viral DNA Polymerase Mutations Associated with Drug Resistance in Human Cytomegalovirus
Chou, S., Lurain, N. S., Thompson, K. D., Miner, R. C., & Drew, W. L. (2003) · The Journal of Infectious Diseases · doi:10.1086/375743 · Cited by 198
Self-citationPrichard, M. N., Gao, N., Jairath, S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5663-5670.1999 · Cited by 193
Bock, C. –., Tillmann, H. L., Torresi, J., Klempnauer, J., Locarnini, S., Manns, M. P., & Trautwein, C. (2002) · Gastroenterology · doi:10.1053/gast.2002.31015 · Cited by 190
Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients
Limaye, A. P. (2002) · Clinical Infectious Diseases · doi:10.1086/342385 · Cited by 185
Inhibition of Hepatitis B Virus Polymerase by Entecavir
Langley, D. R., Walsh, A. W., Baldick, C. J., Eggers, B. J., Rose, R. E., Levine, S. M., Kapur, A. J., Colonno, R. J., & Tenney, D. J. (2007) · Journal of Virology · doi:10.1128/jvi.02395-06 · Cited by 184
Ciesla, S. L., Trahan, J., Wan, W. B., Beadle, J. R., Aldern, K. A., Painter, G. R., & Hostetler, K. Y. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00110-4 · Cited by 176
Yang, H., Qi, X., Sabogal, A., Miller, M., Xiong, S., & Delaney, W. E. (2005) · Antiviral Therapy · doi:10.1177/135965350501000507 · Cited by 170
Wolf, D. G., Courcelle, C. T., Prichard, M. N., & Mocarski, E. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1895 · Cited by 170
Büchler, M., Caillard, S., Barbier, S., Thervet, E., Toupance, O., Mazouz, H., Hurault de Ligny, B., Le Meur, Y., Thierry, A., Villemain, F., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01976.x · Cited by 169
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
Kaptein, S. J. F., Efferth, T., Leis, M., Rechter, S., Auerochs, S., Kalmer, M., Bruggeman, C. A., Vink, C., Stamminger, T., & Marschall, M. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.003 · Cited by 165
Chen, Y., Scieux, C., Garrait, V., Socié, G., Rocha, V., Molina, J., Thouvenot, D., Morfin, F., Hocqueloux, L., Garderet, L., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/314052 · Cited by 165
Angus, P. W., Patterson, S. J., Strasser, S. I., McCaughan, G. W., & Gane, E. (2008) · Hepatology · doi:10.1002/hep.22524 · Cited by 160
Shapira, M. Y., Resnick, I. B., Chou, S., Neumann, A. U., Lurain, N. S., Stamminger, T., Caplan, O., Saleh, N., Efferth, T., Marschall, M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587106 · Cited by 157
Self-citationLandry, M. L., Stanat, S. C., Biron, K. K., Brambilla, D. J., Britt, W. J., Jokela, J. A., Chou, S., Drew, W., Erice, A., Gilliam, B. L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.688-692.2000 · Cited by 155
Self-citationNugier, F., Colin, J., Aymard, M., & Langlois, M. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360102 · Cited by 153
Oral Treatment of Cowpox and Vaccinia Virus Infections in Mice with Ether Lipid Esters of Cidofovir
Quenelle, D. C., Collins, D. J., Wan, W., Beadle, J. R., Hostetler, K. Y., & Kern, E. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.404-412.2004 · Cited by 150
Human embryonic stem cells: A potential source for cellular therapy
Gerecht, S., & Itskovitz‐Eldor, J. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6135.2004.0345.x · Cited by 146
Waldman, W. J., Knight, D. A., Blinder, L., Shen, J., Lurain, N. S., Miller, D. M., Sedmak, D. D., Williams, J. W., & Chong, A. S. (1999) · Intervirology · doi:10.1159/000053979 · Cited by 145
Marty, F. M., Porter, J., Browne, S., Schwarzberg, T., Ho, V. T., Bassett, I. V., Koreth, J., Alyea, E. P., Soiffer, R. J., Cutler, C. S., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069294 · Cited by 142
Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients
Wong, D. K.-H., Yuen, M., Yuan, H., Sum, S. S., Hui, C., Hall, J. G., & Lai, C. (2004) · Hepatology · doi:10.1002/hep.20353 · Cited by 136
Chakrabarti, S., Pillay, D., Ratcliffe, D., Cane, P., Collingham, K. E., & Milligan, D. W. (2000) · The Journal of Infectious Diseases · doi:10.1086/315524 · Cited by 127
Jabs, D. A., Enger, C. L., Forman, M., Dunn, J. P., Retinitis, F. T. C., & Viral Resistance Study Group (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2240 · Cited by 124
Levin, M. J., Dahl, K. M., Weinberg, A., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378502 · Cited by 124
Webster, A. C., Lee, V. W., Chapman, J. R., & Craig, J. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004290.pub2 · Cited by 108
Li, F., Kenyon, K. W., Kirby, K. A., Fishbein, D. P., Boeckh, M., & Limaye, A. P. (2007) · Clinical Infectious Diseases · doi:10.1086/519941 · Cited by 99
Kalil, A. C., Freifeld, A. G., Lyden, E. R., & Stoner, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005512 · Cited by 98
THE IMPACT OF GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION AFTER LUNG TRANSPLANTATION
Kruger, R. M., Shannon, W. D., Arens, M. Q., et al. (1999) · Transplantation · doi:10.1097/00007890-199911150-00010 · Cited by 98
Mutations in the Human Cytomegalovirus UL27 Gene That Confer Resistance to Maribavir
Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., & Biron, K. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7124-7130.2004 · Cited by 90
Self-citationKern, E. R., Kushner, N. L., Hartline, C. B., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1039-1045.2005 · Cited by 82
Laurenti, L., Piccioni, P., Cattani, P., Cingolani, A., Efremov, D., Chiusolo, P., Tarnani, M., Fadda, G., Sica, S., & Leone, G. G. M. (2004) · PubMed · Cited by 79
Antiviral strategies to combat cytomegalovirus infections in transplant recipients
Lischka, P., & ZIMMERMANN, H. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.07.002 · Cited by 77
Demopoulos, L. A., Polinsky, M. S., Steele, G. H., Mines, D. I., Blum, M., Caulfield, M. E., Adamkovic, A., Liu, Q., Harler, M., Hahn, C. M., et al. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.03.084 · Cited by 75
Isada, C. M., Yen‐Lieberman, B., Lurain, N. S., Schilz, R. J., Kohn, D. J., Longworth, D. L., Taege, A. J., Mossad, S. B., Maurer, J., Flechner, S. M., et al. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.t01-1-02008.x · Cited by 68
Seifer, M., Patty, A., Serra, I., Li, B., & Standring, D. N. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.008 · Cited by 55
Nguyen, M. H., & Keeffe, E. B. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01078.x · Cited by 53
The antiviral spectrum of (E)-5-(2-bromovinyl)-2 '-deoxyuridine
Clercq, E. D. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_a.85 · Cited by 53
Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance
Fournier, C., & Zoulim, F. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.08.013 · Cited by 48
Seo, S. K., Regan, A. D., Cihlář, T., Lin, D. C., Boulad, F., George, D., Prasad, V. K., Kiehn, T. E., & Polsky, B. (2001) · Clinical Infectious Diseases · doi:10.1086/323022 · Cited by 48
Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir
Kamiyama, T., Kurokawa, M., & Shiraki, K. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-11-2761 · Cited by 47
Griffiths, A., Chen, S., Horsburgh, B. C., & Coen, D. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4703-4709.2003 · Cited by 42
ACYCLOVIR-RESISTANT CHRONIC VERRUCOUS VACCINE STRAIN VARICELLA IN A PATIENT WITH NEUROBLASTOMA
Bryan, C. J., Prichard, M. N., Daily, S. L., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318175d85c · Cited by 39
Recurrent Herpes Simplex Virus Hepatitis After Liver Retransplantation Despite Acyclovir Therapy
Longerich, T., Eisenbach, C., Penzel, R., Kremer, T. L., Flechtenmacher, C., Helmke, B. M., Encke, J., Kraus, T. W., & Schirmacher, P. (2005) · Liver Transplantation · doi:10.1002/lt.20567 · Cited by 37
Haririan, A., Morawski, K., West, M. S., El‐Amm, J. M., Doshi, M. D., Cincotta, E., Alangaden, G. J., Chandrasekar, P. H., & Gruber, S. A. (2007) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00669.x · Cited by 31
Griffiths, A., Link, M. A., Furness, C. L., & Coen, D. M. (2006) · Journal of Virology · doi:10.1128/jvi.00155-06 · Cited by 30
Schliefer, K., Gümbel, H., Rockstroh, J. K., & Spengler, U. (1999) · Clinical Infectious Diseases · doi:10.1086/598656 · Cited by 21
Cited by
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Multidrug Resistance: An Emerging Crisis
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 657
Nanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Caffeic Acid and Its Derivatives: Antimicrobial Drugs toward Microbial Pathogens
Khan, F., Bamunuarachchi, N. I., Tabassum, N., & Kim, Y.-M. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07579 · Cited by 326
Metal-Based Nanoparticles for the Treatment of Infectious Diseases
Aderibigbe, B. (2017) · Molecules · doi:10.3390/molecules22081370 · Cited by 269
Metadata
- Authors
- Strasfeld, L., & Chou, S.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 24
- Issue
- 2
- Pages
- 413-437
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W2155477672
- Cited by
- 254
- References
- 85
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.